United Therapeutics (Nasdaq: UTHR) is the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies and technologies that expand the availability of transplantable organs. We develop treatments for rare, deadly diseases, with six FDA-approved therapies that treat Pulmonary Arterial Hypertension (PAH), pulmonary hypertension associated with interstitial lung disease (PH-ILD), and neuroblastoma. Our near-term pipeline focuses on developing additional therapies for PAH and pulmonary fibrosis (PF). We are also working to create manufactured organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. As a Remodulin/Orenitram Cardiopulmonary Specialist (ROCPS), you will play a vital role in supporting patients living with pulmonary arterial hypertension (PAH). You will focus on our parenteral and oral therapies—Remodulin® and Orenitram®—while also serving as a trusted resource for healthcare professionals. We are looking for driven, patient-focused individuals who are eager to educate, build strong partnerships, and deliver meaningful results.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior